Casper Marc N's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Nov 12, 2024
- Accession no.
- 0001127602-24-027036
- Filed
- Nov 12, 2024
- Trade date
- Nov 8, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions. Open-market sales total $4.98M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casper Marc NCIK 0001216055 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2024 | Common Stock | SSaleDisposed | −1,258 | $550.87 | −$692,994.46 | 22,350 | Indirect | |
| Nov 8, 2024 | Common Stock | SSaleDisposed | −1,651 | $552.14 | −$911,583.14 | 20,699 | Indirect | |
| Nov 8, 2024 | Common Stock | SSaleDisposed | −3,310 | $553.04 | −$1,830,562.4 | 17,389 | Indirect | |
| Nov 8, 2024 | Common Stock | SSaleDisposed | −2,481 | $553.88 | −$1,374,176.28 | 14,908 | Indirect | |
| Nov 8, 2024 | Common Stock | SSaleDisposed | −300 | $554.83 | −$166,449 | 14,608 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.